Grindeks 02.01.2007 Changes in the Top Management of JSC Grindeks Starting from 2nd of January 2007 Jānis Romanovskis was appointed as the Chairman of the Board of JSC Grindeks, previously operating as the Finance and Administrative Director of the company. On 27th of December 2006 Council of JSC approved decision of the Chairman of the Board JSC Grindeks Valdis Jākobsons to discontinue his activities in the Board of the company. Decision of V. Jākobsons is based on his willingness to decline from the realization of everyday operational activities and focus on the research and new product development related fields. Starting from 2nd of January 2007 Valdis Jākobsons will be operating as a Councillor for the Chairman of the Council of JSC Grindeks. As a main goal for his activities V. Jākobsons has set development of the new research centre. Jānis Romanovskis has been holding a post as a Finance and Administrative Director for JSC Grindeks since 2003; he has also been Member of the Board of the company. In compliance with the decision of Grindeks Council Director of the Finale Dosage Forms Manufacturing Business Unit Lipmans Zeligmans has been elected as a Member of the Board of JSC Grindeks. JSC Grindeks is the leading pharmaceutical company in the Baltic States specializing in the manufacturing and sales of heart and cardiovascular, central nervous system and anti-cancer medications. Its concern consists of four subsidiary companies in Latvia, Estonia and Russia as well as seven representative offices. Products of the company are exported to more than 40 countries. Main markets – Baltic States, Russia, and CIS countries, Japan, USA. Grindeks shares are listed in the Official list of Riga Stock Exchange. Ilze Kreicmane JSC Grindeks Deputy Manager Department of Communications Phone 7083370, 9256012 E-mail: ilze.kreicmane@grindeks.lv